Author: Brett Owens, Contrarian Outlook

This blue-chip Pharma stock now yields 4.5% and is trading for less than 10-times earnings. The stock only goes on sale like this once in a blue moon… and anytime it pays 4.5% or more, it proves to be a screaming deal.

Our opportunity to pounce has arrived… its 14.3% discount won’t last.

History shows anytime it pays 4.5% or more, it proves to be a screaming deal.

I’m closing out my previous “trade of the decade” for this one…

Real estate investment trusts (REITs) are dirt-cheap — but hurry if you like dividends…these generous payers may not be in the bargain bin for much longer.